ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Comorbidity"

  • Abstract Number: 1326 • ACR Convergence 2021

    Epidemiology of Comorbidities in an Incident Psoriasis Cohort: A Population-Based Study

    Paras Karmacharya1, Rikesh Chakradhar2, Alexis Ogdie3, John Davis2, Kerry Wright2, Megha M. Tollefson2, Ali Duarte-Garcia2, Delamo Bekele2, Hilal Maradit Kremers2, Floranne Ernste2, Tina Gunderson2, Cassondra Hulshizer2 and Cynthia Crowson4, 1Mayo Clinic, Rochester MN; Vanderbilt University, Nashville, TN, 2Mayo Clinic, Rochester, MN, 3University of Pennsylvania, Philadelphia, PA, 4Mayo Clinic, Eyota, MN

    Background/Purpose: Psoriasis, a chronic immune-mediated skin disease affecting 2-4% of the US population, is increasingly recognized as a systemic inflammatory disorder associated with cardiometabolic and…
  • Abstract Number: 0574 • ACR Convergence 2021

    Prevalence and Early Progression of Lung Diseases in Patients with Recently-Diagnosed Rheumatoid Arthritis: A Prospective Cohort Study

    Tina Mahajan1, Daniel Hershberger1, Matt Devries2, Punyasha Roul1, Yangyuna Yang1, Sherrie Edwards1, Geoffrey Thiele1, Ted Mikuls1, James O'Dell1 and Bryant England1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Medical Center, Omaha

    Background/Purpose: Several types of lung diseases complicate the rheumatoid arthritis (RA) disease course such as interstitial lung disease (ILD) and obstructive lung diseases. The prevalence…
  • Abstract Number: 1416 • ACR Convergence 2021

    Dysregulated Glucose Metabolism and Dyslipidemia in GCA and PMR Patients at Diagnosis

    Idil Esen1, Philip Therkildsen2, Berit Dalsgaard Nielsen2, Anna van 't Ende1, Annemieke Boots1, Peter Heeringa1, Ellen-Margrethe Hauge2, Elisabeth Brouwer1 and Yannick van Sleen3, 1University Medical Center Groningen, Groningen, Netherlands, 2Aarhus University Hospital, Aarhus, Denmark, 3University of Groningen, Groningen, Netherlands

    Background/Purpose: Giant cell arteritis (GCA) is the large and medium vasculitis that affects elderly people GCA frequently overlaps with polymyalgia rheumatica (PMR). PMR is a…
  • Abstract Number: 0577 • ACR Convergence 2021

    Comorbidity Burden as Scored Using the Rheumatic Disease Comorbidity Index (RDCI) Is Associated with Varying Treatment Patterns in Patients with Inflammatory Arthritis – a Study Using the EHR-Derived Rheumatic and Arthritis Disease Information Registry (RADIR)

    Diviya Rajesh, Deanna Jannat-Khah, Huong Do, Jonah Levine, Medha Barbhaiya, Lisa Mandl and Vivian Bykerk, Hospital for Special Surgery, New York, NY

    Background/Purpose: Higher comorbidity burden (CB) has been associated with treatment choices in RA, but not assessed in populations including multiple forms of inflammatory arthritis (IA)…
  • Abstract Number: 1427 • ACR Convergence 2021

    Reduction of Cardiovascular Disease and Mortality versus Risk of New Onset Diabetes with Statin Use in Patients with Rheumatoid Arthritis

    Gulsen Ozen1, Sophie Dell’Aniello2, Sofia Pedro3, Kaleb Michaud4 and Samy Suissa5, 1University of Nebraska Medical Center, Bellevue, NE, 2Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital, Montréal, QC, Canada, 3Forward, The National Databank for Rheumatic Diseases, Wichita, KS, 4University of Nebraska Medical Center, Omaha, NE, 5Center for Clinical Epidemiology, Lady Davis Research Institute - Jewish General Hospital;Depts of Epidemiology and Biostatistics and of Medicine, McGill University, Montréal, QC, Canada

    Background/Purpose: The risks of death and of type 2 diabetes mellitus (T2DM) are increased in RA mainly due to inflammation mediated accelerated cardiovascular disease (CVD)…
  • Abstract Number: 0584 • ACR Convergence 2021

    High Number of Comorbidities and Concomitant Medications at Baseline in the Glucocorticoid Low-dose Outcome in Rheumatoid Arthritis (GLORIA) Study: An Older Population with Rheumatoid Arthritis

    Maarten Boers1, Linda Hartman1, Daniela Opris-Belinski2, Reinhard Bos3, Marc Kok4, Jose Pereira da Silva5, Eduard N Griep6, Ruth Klaasen7, Cornelia F. Allaart8, Paul Baudoin9, Hennie Raterman10, Zoltan Szekanecz11, Frank Buttgereit12, Pavol Masaryk13, L. Thomas Klausch1, Sabrina Paolino14, Annemarie Schilder15, Willem Lems16 and Maurizio Cutolo14, 1Amsterdam UMC, Vrije Universiteit, Amsterdam, Netherlands, 2Carol Davila University, Bucharest, Romania, 3Department of Rheumatology, Medical Centre Leeuwarden, Leeuwarden, Netherlands, 4Maasstad Hospital, Rotterdam, Netherlands, 5University of Coimbra | UC · Clínica Universitária de Reumatologia. Faculty of Medicine, Columbia, Portugal, 6Antonius Hospital, Leeuwarden, Netherlands, 7Meander Medical Center, Amersfoort, Netherlands, 8Leiden University Medical Center, Leiden, Netherlands, 9Reumazorg ZWN, Almere, Netherlands, 10Northwest Clinics, Alkmaar, Netherlands, 11Division of Rheumatology, University of Debrecen, Faculty of Medicine, Debrecen, Hungary, 12Charité – Universitätsmedizin Berlin, Berlin, Germany, 13National Institute for the Rheumatic Diseases, Bratislava, Slovakia, 14Laboratory of Experimental Rheumatology and Academic Division of Clinical Rheumatology, Department of Internal Medicine, University of Genova, IRCCS Polyclinic San Martino Hospital, Genoa, Italy, 15Medical Centre Leeuwarden, Leeuwarden, Netherlands, 16VUmc, Amsterdam, Netherlands

    Background/Purpose: Older people are often underrepresented in trials because the generally high number of comorbid conditions (1). The objective of this abstract is to document…
  • Abstract Number: 1450 • ACR Convergence 2021

    Unsupervised Machine Learning Methods to Cluster Comorbidities in a Population-based Cohort of Patients with Rheumatoid Arthritis

    Elizabeth Atkinson1, Tina Gunderson1, John Davis1, Elena Myasoedova1, Vanessa Kronzer1, Caitrin Coffey1 and Cynthia Crowson2, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Eyota, MN

    Background/Purpose: Comorbidities are common in patients with rheumatoid arthritis (RA), and comorbidity patterns are of interest. We aimed to examine clusters of comorbidities and clusters…
  • Abstract Number: 0182 • ACR Convergence 2020

    Chronic Kidney Disease Is Underestimated in Patients with Rheumatoid Arthritis – Real World Data Gathered from a Network of Rheumatologists

    Stefan Kleinert1, Peter Bartz-Bazzanella2, Cay von der Decken3, Kirsten Karberg4, Florian Schuch5, Georg Gauler6, Patrick Wurth7, Susanna Spaethling-Mestekemper8, Christoph Kuhn9, Matthias Englbrecht10, Wolfgang Vorbrueggen11 and Martin Welcker12, 1Rheumatology-Nephrology Practice, Erlangen, Germany, 2Department of Rheumatology, Internal Medicine, Rhein-Maas-Hospital, Wuerselen, Germany, 3Medical Centre Stolberg, Stolberg, Germany, 4Practice for Rheumatology and Internal Medicine, Berlin, Germany, 5Rheumatology-Nephrology Practice, Erlangen, 6Rheumatology Practice, Osnabrueck, 7Rheumatology Practice, Osnabrueck, Germany, 8Rheumatology Group Practice, Muenchen, Germany, 9Rheumatology Practice, Karlsruhe, 10Freelance Healthcare Data Scientist, Eckental, Germany, 11Foundation for fostering rheumatology, Wuerselen, Germany, 12MVZ für Rheumatologie Dr. M. Welcker, Planegg, Germany

    Background/Purpose: Patient registries have become a common approach to learn from patient-related data by prospectively including large numbers of individuals into a sample followed over…
  • Abstract Number: 0918 • ACR Convergence 2020

    Decline in Forced Vital Capacity in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) with and Without Gastroesophageal Reflux Disease: Further Analyses of the SENSCIS Trial

    Kristin Highland1, Gerard Criner2, Petros Sfikakis3, Hilario Nunes4, Wendy Stevens5, Corinna Miede6, Margarida Alves7 and Michael Kreuter8, 1Cleveland Clinic, Cleveland, Ohio, USA, Cleveland, OH, 2Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, 3National Kapodistrian University of Athens Medical School, Athens, Greece, 4Department of Pulmonology, Hôpital Avicenne, APHP, Bobigny, France, Bobigny, France, 5Department of Rheumatology, St Vincent's Hospital, Melbourne, Victoria, Australia, Fitzroy, Victoria, Australia, 6mainanalytics GmbH, Sulzbach (Taunus), Germany, Sulzbach (Taunus), Germany, 7Boehringer Ingelheim International GmbH, Ingelheim am Rhein, Germany, Ingelheim am Rhein, Germany, 8Center for Interstitial and Rare Lung Diseases, Pneumology and Respiratory Care Medicine, Thoraxklinik, University of Heidelberg, Member of the German Center for Lung Research, Heidelberg, Germany, Heidelberg, Germany

    Background/Purpose: Gastroesophageal reflux disease (GERD) is a common comorbidity in patients with SSc-ILD and may be associated with progression of SSc-ILD. In the SENSCIS trial…
  • Abstract Number: 1657 • ACR Convergence 2020

    Do Comorbidities Limit Improvement in Pain and Physical Function After Total Knee Arthroplasty in Patients with Knee Osteoarthritis?

    Lauren King1, Esther Waugh1, Allyson Jones2, Deborah Marshall3 and Gillian Hawker4, 1University of Toronto, Toronto, Canada, 2University of Alberta, Edmonton, AB, Canada, 3University of Calgary, Calgary, AB, Canada, 4University of Toronto, Toronto, ON, Canada

    Background/Purpose: Individuals with knee osteoarthritis (OA) are increasingly living with multiple comorbid conditions. The presence of comorbidities has been associated with having worse OA symptoms…
  • Abstract Number: 0183 • ACR Convergence 2020

    Incidence of Malignancies in Japanese Patients with Rheumatoid Arthritis: Data from a Large Japanese National Registry

    Toshihiro Matsui1, Naonobu Sugiyama2, Tsutomu Kawaguchi2, Aosa Kamezaki2, Shigeyuki Toyoizumi3, Fujio Matsuyama4, Tatsunori Murata4, Yukitomo Urata5, Kimito Kawahata6 and Shigeto Tohma7, 1Department of Rheumatology, Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara, Japan, 2Pfizer Japan Inc, Tokyo, Japan, 3Pfizer R&D Japan G.K., Tokyo, Japan, 4CRECON Medical Assessment Inc, Tokyo, Japan, 5Department of Rheumatology, Tsugaru General Hospital, Aomori, Japan, 6Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan, 7National Hospital Organization Tokyo National Hospital, Tokyo, Japan

    Background/Purpose: Patients (pts) with RA have an increased risk of some malignancies compared with the general population, and this can vary by region/race.1,2 Epidemiologic data…
  • Abstract Number: 0963 • ACR Convergence 2020

    Chronic Obstructive Pulmonary Disease Associated with Prolonged Opiate Use, Increased Short-Term Complications and the Need for Revision Surgery Following Total Knee Arthroplasty

    Jillian Glasser1, Nicholas Lemme2, Daniel Yang2, Edward Testa2, Alan Daniels3 and Valentin Antoci3, 1University Orthopedics Inc, East Providence, RI, 2Warren Alpert School of Medicine, Providence, RI, 3Warren Alpert School of Medicine, East Providence, RI

    Background/Purpose: Chronic obstructive pulmonary disease (COPD) is a condition which causes a substantial burden to patients, physicians, and the healthcare system at large. Medical comorbidities…
  • Abstract Number: 1727 • ACR Convergence 2020

    Patterns of Fatigue in Early RA over 10 Years: Results from the ESPOIR Cohort

    Samantha Rodriguez-Muguruza1, Bernard Combe2, Oliver Valero3, Francis Guillemin4, Alejandro Olivé-Marqués5, Bruno Fautrel6, Ramon Fontova1 and Cédric Lukas7, 1Joan XXIII Hospital, Tarragona, Spain, 2University of Montpellier, Montpellier, France, 3Department of Statistics, Autonoma de Barcelona University, Barcelona, Spain, 4Universite de Lorraine CIC INSERM, Nancy, France, 5Hospital Germans Trias i Pujol, Barcelona, Spain, 6Sorbonne University, INSERM, IPLES; Pitié-Salpêtrière Hospital, Paris, Ile-de-France, France, 7CHU Montpellier and University of Montpellier, Montpellier, France

    Background/Purpose: to determine and characterize fatigue trajectories over 10 years of follow-up in a cohort of early RA patients. Methods: We selected patients fulfilling the 2010…
  • Abstract Number: 0190 • ACR Convergence 2020

    Hepatic Steatosis in Rheumatoid Arthritis: Frequency and Disease-Related Contributors

    Jun Lee1, Galina Lagos2, Joan Bathon1 and Jon Giles1, 1Division of Rheumatology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, 2Columbia University Vagelos College of Physicians and Surgeons, New York

    Background/Purpose: Nonalcoholic fatty liver disease (NAFLD), a spectrum of disorders characterized by the presence of hepatic steatosis, is the most common liver disorder in western…
  • Abstract Number: 1021 • ACR Convergence 2020

    Organ Damage in Systemic Lupus Erythematosus Is Attributable More to Comorbidity (Hypertension) and Less to Socioeconomic Status

    Romy Kallas1, Jessica Li2, Daniel Goldman3 and Michelle Petri3, 1Johns Hopkins Medical Institution, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD, 3Johns Hopkins University School of Medicine, Timonium, MD

    Background/Purpose: Multiple variables are known to contribute to development of organ damage in SLE patients, including prednisone use and ethnicity. The aim of this study…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 22
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology